Phytochemical study on the plant Premna integrifolia L. led to the isolation of twelve compounds. In which, a new acylated iridoid glycoside, 6-O-(3″-O-acetyl-2″-O-trans-p-coumaroyl)-α-L-rhamnopyranosylcatalpol (premnacorymboside A) (1), was isolated from the flowers along with 10-O-trans-p-methoxycinnamoylcatalpol (3) and verbascoside. From the leaves, a new iridoid glycoside, 6-O-(3″-O-trans-p-coumaroyl)-α-L-rhamnopyranosylcatalpol (premnacorymboside B) (2), together with 10-O-trans-p-methoxycinnamoylcatalpol (3), scutellarioside II (4), premnaodoroside A (5), 1-O-trans-p-coumaroyl-α-Lrhamnopyranoside, hexyl glucoside, 4-hydroxy-2-methoxybenzaldehyde, and 4-hydroxybenzaldehyde were obtained. The new compound premnacorymboside A (1) and scutellarioside II (4), were also isolated from the stem bark along with quercetin 3rutinoside and leonuriside A. The structure determinations were based on physical and spectroscopic evidence.
The plant Premna integrifolia L. [synonyms: P. corymbosa Rottl. et Willd., P. obtusifolia R. Br.] belongs to the family Verbenaceae, widely distributed in Vietnam, Laos, and Cambodia. In Vietnamese traditional medicine, the leaves of this plant are used to treat indigestion, dysuria, and dysentery. The roots are also employed against indigestion, stomachache, and fever [1] . Previous phytochemical investigations on the Premna species reported the isolation and structural identification of a number of iridoid glycosides [2] . This type of compounds occupies an important position in the field of natural product chemistry and biology [3] . A number of them displayed an interesting spectrum of biological activities such as antidiabetic, neuroprotective, nerve growth factor-potentiating, and hepatocurative activities [4] . In the course of our phytochemical study on the plant P. integrifolia, this paper deals with the isolation and structural elucidation of two new iridoid glycosides, premnacorymbosides A (1) and B (2), along with ten known compounds including 10-O-trans-pmethoxycinnamoylcatalpol (3), scutellarioside II (4), premnaodoroside A (5), verbascoside, quercetin 3rutinoside, leonuriside A, 1-O-trans-p-coumaroyl-α-L-rhamnopyranoside, hexyl glucoside, 4-hydroxy-2methoxybenzaldehyde, and 4-hydroxybenzaldehyde. Considering the interesting bioactivities of iridoid glycosides [4], compounds 1-5 are probable active, which will be the work in our future study. Moreover, the 1 H-NMR spectrum of 1 showed all the typical signals of a catalpol diglycoside [5a] , with two characteristic anomeric protons appearing as doublets at δ 4.80 (1H, d, J = 8.0 Hz, H-1′) and 5.06 (1H, d, J = 1.5 Hz, H-1′′), indicating β-glucopyranose and α-rhamnopyranose to be sugar moieties. The 13 C NMR spectrum of 1 showed 32 carbon signals, including 23 methine, 2 methylene, 2 methyl and 5 quaternary carbons, detected by the DEPT experiments. In which, the trans-p-coumaroyl moiety was indicated by signals at δ 127.0 (C, C-1′′′), 131.4 (CH, C-2′′′ and C-3′′′), 116.9 (CH, C-3′′′ and C-5′′′), 161.5 (C, C-6′′′), 147.6 (CH, C-7′′′), 114.4 (CH, C-8′′′), and 168.1 (C, C-9′′′) [5b] . The signals at δ 172.3 (C, C-1′′′′) and 20.9 (CH 3 , C-2′′′′) identified the presence of an acetoxyl group. The other signals (Table 1) were due to a catalpol diglycoside part [3,5a] . The NMR spectral data of 1 were in excellent agreement with those of scrophuloside A 3 [5b] . The differences between the two compounds were only observed in the signals of the α-L-rhamnopyranosyl moiety, indicating that 1 is an isomer of the esterification positions of scrophuloside A 3 . All the NMR spectral data of 1 were assigned by comparison with those of scrophuloside A Compound 2 was also obtained as white amorphous powder. 3 (9) 2008 1451 similar to those of 1 (Table 1) . The easily visible change is the absence of the acetoxyl group signals. The esterification of the trans-p-coumaroyl moiety at C-3′′ was identified by comparison the NMR spectral data of 2 with those of 6-O-(3′′′-O-isoferuloyl)-α-Lrhamnopyranosylcatalpol [2a] , and further confirmed by the HMBC cross peak from proton H-3′′ (δ 5.13) and C-9′′′ (δ 168.9). Finally, the L-rhamnopyranose and D-glucopyranose were identified by HPLC after acidic hydrolysis of 2 with 1 N HCl (see Experimental). Accordingly, the structure of 2 were defined to be 6-O-(3″-O-trans-p-coumaroyl)-α-Lrhamnopyranosylcatalpol, a new compound named as premnacorymboside B.
Detailed analysis of the 1D and 2D NMR spectral data and comparison of them with the literature values allowed to characterize the other compounds as 10-O-trans-p-methoxycinnamoylcatalpol (3), [7] , hexyl glucoside [8] , 4-hydroxy-2-methoxybenzaldehyde, and 4-hydroxybenzaldehyde [9] .
Experimental
General: Optical rotations were determined on a JASCO DIP-1000 KUY polarimeter. All NMR spectra were recorded on a Bruker AM500 FT-NMR spectrometer (500 MHz for 1 H and 125 MHz for 13 C), and chemical shifts (δ) are reported in ppm using tetramethylsilane (TMS) as an internal standard. The HREIMS was obtained on JEOL JMSHX-100 mass spectrometer. The ESI-MS was obtained on an AGILENT 1200 SERIES LC-MSD Trap spectrometer. Column chromatography (CC) was performed on silica gel 230 -400 mesh (0,040 -0,063 mm, Merck) or YMC RP-18 resins (30 -50 μm, Fujisilisa Chemical Ltd.). Thin layer chromatography (TLC) was performed on DC-Alufolien 60 F 254 (Merck 1.05715) or RP 18 F 254s (Merck) plates. Spots were visualized by spraying 10% H 2 SO 4 aqueous and heating for 5 minutes.
Plant materials:
The specimens of P. integrifolia were collected in Truc Dong, Truc Ninh, Nam Dinh province, Vietnam during July, 2007 and identified by Prof. Vu Van Chuyen, Hanoi University of Pharmacy, Hanoi, Vietnam. A voucher of specimen was deposited at the Herbarium of Hanoi University of Pharmacy.
Extraction and isolation:
The dried flowers (0.5 kg), leaves (2 kg), and stem bark (1 kg) of the P. integrifolia (5 kg) were separately powdered and extracted three times with hot MeOH (50 o C) to give the corresponding extracts: F (6 g), L (20 g), and S (10 g). The F extract was suspended in water and extracted in turn with chloroform and ethyl acetate. The water layer (5 g) was crudely separated on normal phase silica gel CC using stepwise gradient elution with the solvents chloroform/methanol (50/1 → 1/1), to divide the fraction into five subfractions F1 -F5. The new compound 1 (20 mg, white powder) along with 3 (8 mg, white powder) and verbascoside (12 mg, yellow powder) were isolated from the subfraction F4 (1 g) by reversed phase silica gel (RP-18) CC eluted with MeOH/water 2/1. The L extract was treated by the same manner as done for the F extract. Compounds 4-hydroxy-2-methoxybenzaldehyde (7 mg) and 4-hydroxybenzaldehyde (9 mg) were obtained as white needles by repeatedly normal phase silica gel CC eluting with n-hexane/acetone 15/1 from the chloroform layer. The ethyl acetate extract (10 g) was crudely separated on normal phase silica gel CC using stepwise gradient elution with the solvents chloroform/methanol (50/1 → 1/1), to give nine subfractions L1 -L9. Normal phase silica gel CC of the L3 subfraction (1.5 g) eluted with chloroform/acetone/water 1/1/0.05 gave compounds 1-O-trans-p-coumaroyl-α-L-rhamnopyranoside (8 mg) and hexyl glucoside (10 mg) as white crystals. The new compound 2 (10 mg), along with 3 (15 mg), 4 (10 mg) and 5 (7 mg) were obtained as white powders from the subfraction L6 (2 g) by repeated normal phase silica gel CC eluted with chloroform/acetone/water 1/5/0.25. The S extract was directly separated on normal phase silica gel CC using stepwise gradient elution with the solvents chloroform/methanol (50/1 → 1/1), to obtain seven subfractions S1-S7. Repeated normal phase silica gel CC of the subfraction S3 (2 g), eluting with chloroform/methanol/water 10/1/0.1, obtained compound 4 (11 mg, white powder) and leonuriside A (24 mg, white needles). The new compound 1 (10 mg, white powder) was obtained again (detected by TLC, MS, and NMR experiments) from the subfraction S5 (1 g) along with quercetin 3-rutinoside (9 mg, yellow powder). 
Acid hydrolysis of compounds 1 and 2:
A solution of each compound (1 and 2, 2.0 mg each) in 1 N HCl (1 mL) was stirred at 80 o C in a sealed reaction vial for 2h. After cooling, the solution was diluted with H 2 O (2 mL), passed through a BondElut ® JR-C18 (Varian), and rinsed with H 2 O (2 mL). The water eluate was collected and submitted to HPLC analysis of the sugars. The HPLC conditions for sugars analyses were: solvent 75% MeCN; column, Capcell Pak NH 2 120Å (4.6 i.d.×250 mm, Shiseido); detector, Shimazu RID-10A; flow rate, 1.0 mL/min; temperature, 30 o C. Peaks of the sugars were detected by comparison with those of authentic samples of Lrhamnose and D-glucose (Merck).
